A randomized controlled trial of methotrexate and cyclosporine in the treatment of psoriasis.
Bigby
Michael
M
Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, Mass. 02214, USA.
D000293:Adolescent; D000328:Adult; D016572:Cyclosporine / Q000008:administration & dosage / Q000627:therapeutic use*; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage / Q000627:therapeutic use*; D015337:Multicenter Studies as Topic; D009426:Netherlands; D011565:Psoriasis / Q000188:drug therapy* / Q000473:pathology; D016032:Randomized Controlled Trials as Topic; D012720:Severity of Illness Index; D016896:Treatment Outcome
D003879:Dermatologic Agents; D016572:Cyclosporine; D008727:Methotrexate